Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | UBE2N | P61088 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 3/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13005703 | 1.00 | OPRD1 (0.42) | OPRD1HTR2AHRH1CALM1CAMKK2 | |
| SCHEMBL13005554 | 0.89 | OPRD1 (0.53) | OPRD1HTR2AHRH1CALM1CAMKK2 | |
| SCHEMBL13061012 | 0.89 | OPRD1 (0.46) | OPRD1HTR2AHRH1CALM1CAMKK2 | |
| SCHEMBL13061035 | 0.89 | OPRD1 (0.46) | OPRD1HTR2AHRH1CALM1CAMKK2 | |
| SCHEMBL525395 | 0.85 | OPRD1 (0.52) | OPRD1HTR2AHRH1CHRM1SIGMAR1 | |
| SCHEMBL13005440 | 0.80 | CALM1 (0.59) | OPRD1HTR2AHRH1CALM1CAMKK2 | |
| SCHEMBL9856741 | 0.79 | HTR2A (0.49) | HTR2AHRH1CHRM1UBE2NSIGMAR1 | |
| SCHEMBL13005414 | 0.77 | BCHE (0.56) | CALM1CAMKK2CHRM1BCHESIGMAR1 | |
| SCHEMBL13005430 | 0.77 | CALM1 (0.52) | OPRD1CALM1CAMKK2BCHESIGMAR1 | |
| SCHEMBL13005422 | 0.76 | CALM1 (0.48) | OPRD1CALM1CAMKK2CETPBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851637-B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2010-12-14 | — | — | US | disclosed |